Mr. Speaker, I thank the hon. member for his question.
I understand the concerns of Nova Scotia on this issue. However, my role and the role of Health Canada is that of a regulator. We licence and inspect such a facility wherever it is built in Canada and we approve its products.
Now that the concerns of the Canadian blood agency have been addressed by the blue ribbon panel which was selected and put in place by the ministers of health across the country, I hope and expect this dossier will move forward expeditiously.